Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-09-23
2011-10-11
Barnhart, Lora E (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S001100, C514S021400, C514S021920
Reexamination Certificate
active
08034777
ABSTRACT:
The invention comprises a composition of matter and method of its use for the treatment of multiple sclerosis in humans. The composition is a modified anticholinergic alpha-neurotoxin. Alpha-neurotoxin solution, such as cobratoxin, is filter sterilized to remove bacteria. It is modified using H2O2. Any suitable preservative for parenteral administration can be employed such as methyl paraben, benzalkonium chloride or metacreosol. It is preferred that the composition is administered every other day or daily. The composition may be administered orally, subcutaneously, intramuscularly or intravenously. Parenterally, either subcutaneous or intramuscular injection is preferred.
REFERENCES:
patent: 3624218 (1971-11-01), Regelson
patent: 3888977 (1975-06-01), Sanders
patent: 4113858 (1978-09-01), Hashim
patent: 4126676 (1978-11-01), Sanders
patent: 4162303 (1979-07-01), Sanders
patent: 4341762 (1982-07-01), Haast
patent: 4741902 (1988-05-01), Haast
patent: 5989803 (1999-11-01), Tabas et al.
patent: 5989857 (1999-11-01), Mundschenk
patent: 2005/0069525 (2005-03-01), Mikael
“Saline.” Available online at http://www.merriam-webster.com/medlineplus/saline. Accessed Mar. 25, 2010. 1 page.
Yourist, J.E., Haines, H.G. and Miller K.D., Inhibition of Herpes Simplex Virus Replication by Cobra Alpha-Neurotoxoid, J. Gen Virol. 64:1475-1481 (1983).
Hudson, R.A., Montgomery, I.N. and Rauch H.C., Experimental Allergic Encephalomyelitis: Prevention With a Nontoxic Derivative of a Cobra Neurotoxin, Mol. Immunol. 20(2):229-232 (1983).
Miller, K., Miller G.G., Sanders M. and Fellowes O.N., Inhibition of Virus-Induced Plaque Formation by Atoxic Derivatives of Purified Cobra Neurotoxins, Biophys. et Biophysica Acta 496:192-196 (1977).
Montsdeoca, G. and Stoik, R., Human Clinical Trials on the Effect of Pepteron for Rheumatoid Arthritis, Soc. Exp. Biol. Med., S.E. Sect., vol. 10, p. 9 (1985).
Sanders M. and Fellowes O., Use of Detoxified Snake Neurotoxin as a Partial Treatment for Amyotrophic Lateral Sclerosis, Cancer Cytology 15(2):11-16 (1975).
Raymond Laurence N.
Reid Paul F.
Barnhart Lora E
McLaren Legal Services
McLaren, Esq. Margaret J.
Receptopharm, Inc.
LandOfFree
Modified anticholinergic neurotoxins as modulators of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified anticholinergic neurotoxins as modulators of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified anticholinergic neurotoxins as modulators of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4253306